FDA approves first treatment for COVID-19

22 October 2020 - Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult ...

Read more →

Nexplanon recommended after second submission

22 October 2020 - The first submission was withdrawn. ...

Read more →

Will HIRA resume talk to grant benefits for anti-diabetic combo drugs?

22 October 2020 - Three makers of SGLT-2 inhibiting anti-diabetic drugs said they would seek changes in approval conditions to ...

Read more →

CADTH in favour of new indication for Soliris

22 October 2020 - CADTH has finalised its assessment of eculizumab for adult patients with refractory generalised myasthenia gravis. ...

Read more →

Trump promised seniors drug discount cards. They may be illegal.

22 October 2020 - A proposal announced by President Trump last month was to send older Americans $200 discount cards to ...

Read more →

Remdesivir’s hefty price tag ignores NIH investment in its creation

22 October 2020 - Throughout the Democratic presidential primary, candidates cast a spotlight on the broken U.S. health care system ...

Read more →

Budget is why PHARMAC is letting down New Zealanders, CEO says

22 October 2020 - PHARMAC is struggling to cater to the demand of Kiwis. ...

Read more →

PHARMAC decision pending on life-changing diabetes medications

22 October 2020 - Government drug-funding agency PHARMAC is expected to decide next week whether it will fund two new ...

Read more →

Leo Pharma announces U.S. FDA approval for Enstilar (calcipotriene and betamethasone dipropionate) foam U.S. Prescribing Information update to include data in long-term use in plaque psoriasis treatment

22 October 2020 - U.S. Prescribing Information updated to include PSO-LONG clinical trial data concerning long-term use (52 weeks) of twice-weekly ...

Read more →

F2G receives second US FDA breakthrough therapy designation for Olorofim

22 October 2020 - In Phase 2b development for the treatment of life-threatening fungal infections. ...

Read more →

Patients, health organisations band together to bring breakthrough treatments to Canada sooner

21 October 2020 - Thirteen health charities and patient groups are calling on the Canadian government to improve access to ...

Read more →

$10,000 on new drugs every four months keeps melanoma patient alive

21 October 2020 - Graham Venning was given “weeks perhaps months” to live at the start of the year but ...

Read more →

Priority review granted to Ascentage Pharma's new drug application for olverembatinib (HQP1351), the first third generation BCR-ABL inhibitor in China

21 October 2020 - Ascentage Pharma today announced that the Center for Drug Evaluation of China's National Medical Products Administration has ...

Read more →

U.S. FDA grants fast track designation for ASP0367/MA-0211, a selective PPARδ modulator being developed for the treatment of primary mitochondrial myopathies

20 October 2020 - Astellas Pharma today announced that the U.S. FDA has granted fast track designation for the development ...

Read more →

A prescription for America’s drug pricing problem?

21 October 2020 - Sky-high prescription drug costs remains one of the most hotly contested issues in healthcare today.  ...

Read more →